Clinical Trial Update: Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma [Phase 1]

View source ↗

Summary

This Phase 1 study assessed a multi-modal immunotherapy regimen for metastatic melanoma including cyclophosphamide and fludarabine chemotherapy, vaccine therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Aldesleukin (interleukin-2)
• Cytoxan (cyclophosphamide)
• Fludara (fludarabine)
• Gene-modified white blood cell infusions
• Vaccine therapy

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Melanoma (Skin) | Phase 1 | Status: COMPLETED